Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy-Reference-Cited by-同舟云学术

Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy

Published:2012-01-13 Issue:6 Volume:53 Page:1057-1061
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Kleber Martina¹,Udi Josefina¹,Metzke Barbara¹,Terpos Evangelos²,Roodmann G. David³,Morgan Gareth⁴,Dispenzieri Angela⁵,Einsele Hermann⁶,Wäsch Ralph¹,Engelhardt Monika¹

Affiliation:

1. Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany

2. Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece

3. Division of Hematology/Oncology, University of Pittsburg, Pittsburg, PA, USA

4. Department of Hematology/Oncology, The Leukemia and Myeloma Program, Wimbledon, UK

5. Department of Hematology, Mayo Clinic, Rochester, MN, USA

6. Department of Internal Medicine, University Hospital Würzburg, Würzburg, Germany

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.644548

Reference17 articles.

1. Bisphosphonates: Clinical Experience

2. Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

3. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma

4. Fracture Risk in Monoclonal Gammopathy of Undetermined Significance

5. Advances in the Biology and Treatment of Bone Disease in Multiple Myeloma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal antibodies against RANKL and sclerostin for myeloma-related bone disease: can they change the standard of care?;Expert Review of Hematology;2019-07-16

2. The expression and role of miR-181a in multiple myeloma;Medicine;2018-08

3. European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications;Haematologica;2015-10-01

4. Can oncology recapitulate paleontology? Lessons from species extinctions;Nature Reviews Clinical Oncology;2015-02-17

5. Basisdiagnose, klinisches Spektrum von Plasmazellerkrankungen und Risikostratifizierung;Der Onkologe;2014-03